本页面由Tiger Trade Technology Pte. Ltd.提供服务

BioNexus Gene Lab Corp.

2.18
-0.0023-0.11%
盘后2.180.00000.00%18:40 EDT
成交量:8,361.00
成交额:1.84万
市值:526.42万
市盈率:-1.70
高:2.24
开:2.19
低:2.18
收:2.18
52周最高:15.60
52周最低:1.92
股本:241.73万
流通股本:175.35万
量比:3.17
换手率:0.48%
股息:- -
股息率:- -
每股收益(TTM):-1.2783
每股收益(LYR):-0.8970
净资产收益率:-28.35%
总资产收益率:-16.43%
市净率:0.77
市盈率(LYR):-2.43

数据加载中...

2023/07/24

重要事件披露

Form 8-K - Current report
2023/07/20

重要事件披露

Form 8-K - Current report
2023/07/17

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2023/07/05

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2023/05/09

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/05/09

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2023/03/31

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/02/14

招股说明书

S-1 - General form for registration of securities under the Securities Act of 1933
2022/11/14

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/08/15

重要事件披露

8-K - Current report
2022/08/15

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/05/16

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/04/06

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2020/11/09

[修订]季度报告

10-Q/A [Amend] - Quarterly report [Sections 13 or 15(d)]
2020/11/03

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/10/08

重要事件披露

8-K - Current report
2020/08/11

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/05/08

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/03/31

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2019/11/14

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]